PPAR-gamma receptor agonists--a review of their role in diabetic management in Trinidad and Tobago.

Abstract excerpt

The PPAR-gamma receptor agonists, as a relatively new and perhaps still not very widely used class of antidiabetic agent in the Caribbean and particularly the Trinidadian context, possess pharmacologic properties that certainly have been shown to have impact on many of the inflammatory, metabolic, biochemical and structural macrovascular aberrations that occur in the type 2 diabetic. Activation of PPAR(gamma)...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Carbohydrate Metabolism
• Share to Diabetic Angiopathies
• Share to Extracellular Signal-Regulated MAP Kinases